Daniel started in the pharmaceutical industry in 2005. He joined Consilient Health in 2016 and is responsible for establishing and growing the Company’s secondary care business. In his role, Daniel works closely with manufacturing partners and business development functions to bring injectable medicines and oral solid dose products to the market.
Prior to his role at Consilient Health, Daniel held the role of Regional Director for the UK and Ireland at Accord Healthcare. During his time at Accord he established and grew the hospital business to become a major player in the UK and Irish markets. Daniel has also held several positions within Teva, working in its secondary care and branded business.
Daniel has a BSc (Hons) in Human Biology from Staffordshire University.
Code No: UK/CH/0319/0059 Date of Preparation: March 2019